Clinical Research Stocks List Ranked for 2024 |

Symbol	Grade	Name	% Change
DVA	C	DaVita HealthCare Partners Inc.	1.70
SUPN	C	Supernus Pharmaceuticals, Inc.	-0.83
RCEL	B	Avita Medical Limited	-1.38
CORT	B	Corcept Therapeutics Incorporated	-0.30
OMER	A	Omeros Corporation	28.19

Symbol	Grade	Name	Weight
BBH	D	Market Vectors Biotech ETF	6.9
IBBQ	D	Invesco Nasdaq Biotechnology ETF	5.67
IBB	D	iShares Nasdaq Biotechnology Index Fund	5.67
CANC	D	Tema Oncology ETF	5.25
MNTL	D	Tema Neuroscience and Mental Health ETF	4.53

Compare ETFs

Date	Stock	Title
Nov 21	CORT	3 Reasons Growth Investors Will Love Corcept (CORT)
Nov 21	OMER	Omeros Corporation Provides Update on Progress Toward BLA Resubmission
Nov 20	DVA	When Should You Buy DaVita Inc. (NYSE:DVA)?
Nov 20	CORT	Wall Street Analysts Think Corcept (CORT) Could Surge 37.91%: Read This Before Placing a Bet
Nov 17	DVA	Alkermes, DaVita, Jabil, Ralph Lauren, among potential M&A candidates - BofA
Nov 17	DVA	Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul
Nov 17	OMER	Omeros Q3 2024 - Updates On OMIDRIA And Narsoplimab Lead To Liquidity Concerns

Clinical Research: Clinical research is a branch of healthcare science that determines the safety and effectiveness (efficacy) of medications, devices, diagnostic products and treatment regimens intended for human use. These may be used for prevention, treatment, diagnosis or for relieving symptoms of a disease. Clinical research is different from clinical practice. In clinical practice established treatments are used, while in clinical research evidence is collected to establish a treatment.